Qvt Financial LP Roivant Sciences Ltd. Transaction History
Qvt Financial LP
- $966 Million
- Q2 2024
A detailed history of Qvt Financial LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Qvt Financial LP holds 66,719,779 shares of ROIV stock, worth $753 Million. This represents 72.99% of its overall portfolio holdings.
Number of Shares
66,719,779
Previous 66,719,779
-0.0%
Holding current value
$753 Million
Previous $703 Million
0.28%
% of portfolio
72.99%
Previous 65.04%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
308Shares Held
496MCall Options Held
989KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$805 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$780 Million2.91% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$399 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$331 Million0.02% of portfolio
-
Rubric Capital Management LP New York, NY23MShares$259 Million7.2% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.95B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...